ADC Therapeutics SA Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q1 2023 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
ADC Therapeutics SA quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2023 to Q1 2024.
- ADC Therapeutics SA Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$531K, a 47.7% increase year-over-year.
- ADC Therapeutics SA annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$3.22M, a 368% decline from 2022.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)